Article
The 11482G >A polymorphism in the perilipin gene is associated with weight gain with rosiglitazone treatment in type 2 diabetes.
Diabetes care - 1 Jun 2006
Kang Eun Seok, Cha Bong Soo, Kim Hyeong Jin, Kim Hae Jin, Kim So Hun, Hur Kyu Yeon, Lee Hyun Joo, Shim Wan Sub, Ahn Chul Woo, Lee Hyun Chul
Abstract excerpt
OBJECTIVE: The aim of this study was to examine the effects of perilipin gene (PLIN) polymorphisms on weight gain with rosiglitazone treatment in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 160 type 2 diabetic patients were treated with rosiglitazone (4 mg/day) for 12 weeks in addition to their previous medications, which were unchanged. Four single nucleotide polymorphisms (SNPs) at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
